| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.081 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |